Graham Capital Management’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$397K Sell
6,701
-493
-7% -$32K 0.01% 704
2025
Q4
$444K Sell
7,194
-192
-3% -$11.8K 0.01% 673
2025
Q3
$461K Buy
+7,386
New +$514K 0.01% 652
2023
Q3
Sell
-11,875
Closed -$706K 1222
2023
Q2
$706K Buy
+11,875
New +$711K 0.02% 462
2022
Q2
Sell
-31,630
Closed -$1.67M 1188
2022
Q1
$1.67M Buy
+31,630
New +$1.83M 0.06% 163

Other funds holding PBH

Graham Capital Management's PBH Position: Q1 2026 in Review

Graham Capital Management reduced its Prestige Consumer Healthcare (PBH) stake by 6.9% in Q1 2026, selling an estimated $32K and leaving 6,701 shares worth $397K. The position accounts for 0.01% of the portfolio, ranked #704.

Graham Capital Management first reported a position in PBH in Q1 2022 and has held it in 5 quarters since. The position peaked at $1.67M in Q1 2022. 355 funds tracked by Wall St. Rank hold PBH as of Q1 2026.

  • Graham Capital Management held 6,701 shares of Prestige Consumer Healthcare worth $397K as of Q1 2026.
  • Graham Capital Management sold 493 Prestige Consumer Healthcare shares in Q1 2026, an estimated $32K.
  • Prestige Consumer Healthcare made up 0.01% of Graham Capital Management's portfolio in Q1 2026, its #704 holding.
  • Graham Capital Management first reported a position in Prestige Consumer Healthcare in Q1 2022 and has held it in 5 quarters since.
  • Graham Capital Management's Prestige Consumer Healthcare position peaked at $1.67M in Q1 2022.
  • 355 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q1 2026.

Based on Graham Capital Management's 13F filing for Q1 2026, filed 15 May 2026.